Zobrazeno 1 - 10
of 736
pro vyhledávání: '"Patiromer"'
Autor:
Mohamed Abuelazm, Amr Badr, Mustafa Turkmani, Mostafa Atef Amin, Ahmed Mazen Amin, Aya Aboutaleb, Ibrahim Gowaily, Youssef Soliman, Basel Abdelazeem
Publikováno v:
ESC Heart Failure, Vol 11, Iss 1, Pp 28-43 (2024)
Abstract Guideline‐directed medical therapy (GDMT) has improved outcomes in patients with heart failure, including the use of renin–angiotensin–aldosterone system inhibitors, which can hinder the excretion of potassium, resulting in hyperkalaem
Externí odkaz:
https://doaj.org/article/d4d69c3960224824913b3985e295843c
Autor:
Patricia de Sequera, Ramón Bover, Yoana Ivanova-Markova, Alexandra Ivanova, Almudena González-Domínguez, Marta Valls, Verónica Campos
Publikováno v:
Nefrología (English Edition), Vol 43, Iss 6, Pp 721-730 (2023)
Introduction: Chronic hyperkalemia has negative consequences in the medium and long term, and determines the suspension of nephro and cardioprotective drugs, such as renin–angiotensin–aldosterone system inhibitors (RAASi). There is an alternative
Externí odkaz:
https://doaj.org/article/3e9ea51016984ba79f4a2061d0b1b55f
Autor:
Alberto Ortiz, Carmen del Arco Galán, José Carlos Fernández-García, Jorge Gómez Cerezo, Rosa Ibán Ochoa, Julio Núñez, Francisco Pita Gutiérrez, Juan F. Navarro-González
Publikováno v:
Nefrología (English Edition), Vol 43, Iss 6, Pp 765-782 (2023)
Hyperkalaemia is a common electrolyte imbalance with potentially serious short-, medium- and long-term consequences on morbidity and mortality rates and the use of national health service resources. The fact that different medical specialities can ma
Externí odkaz:
https://doaj.org/article/c78ac5e20a4848d6aa1001a22475d76d
Autor:
Patricia de Sequera, Ramón Bover, Yoana Ivanova-Markova, Alexandra Ivanova, Almudena González-Domínguez, Marta Valls, Verónica Campos
Publikováno v:
Nefrología, Vol 43, Iss 6, Pp 721-730 (2023)
Resumen: Introducción: La hiperpotasemia crónica tiene consecuencias negativas a medio y largo plazo, condicionando generalmente la suspensión de fármacos nefro y cardioprotectores, en pacientes con enfermedad renal crónica (ERC) e insuficiencia
Externí odkaz:
https://doaj.org/article/44021fac541d4fbe9db7f096cd07c511
Autor:
Alberto Ortiz, Carmen del Arco Galán, José Carlos Fernández-García, Jorge Gómez Cerezo, Rosa Ibán Ochoa, Julio Núñez, Francisco Pita Gutiérrez, Juan F. Navarro-González
Publikováno v:
Nefrología, Vol 43, Iss 6, Pp 765-782 (2023)
Resumen: La hiperpotasemia es una alteración electrolítica frecuente con consecuencias potencialmente graves a corto, medio y largo plazo, tanto en términos de morbilidad y mortalidad como de consumo de recursos del Sistema Nacional de Salud. El a
Externí odkaz:
https://doaj.org/article/c140f2093def4977a7a68701e923eee5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
AAPS Open, Vol 9, Iss 1, Pp 1-7 (2023)
Abstract Patiromer powder for oral suspension (patiromer o.s.) is a once-daily, potassium (K+) binder approved for the treatment of hyperkalemia. It is known that patiromer o.s. can be mixed with water, apple juice, or cranberry juice. This in vitro
Externí odkaz:
https://doaj.org/article/cf2a87a5c2dc4387b1842fcca6c43294
Publikováno v:
Kidney Medicine, Vol 6, Iss 1, Pp 100757- (2024)
Rationale & Objective: Patiromer is a potassium binder approved for the long-term management of hyperkalemia. Although patiromer use among patients with advanced chronic kidney disease (CKD) has been shown to reduce the discontinuation of renin-angio
Externí odkaz:
https://doaj.org/article/08e89f4d0a204cf791f434b03ff766f3
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 26 (2023)
Hyperkalemia is a common electrolyte disorder in patients with chronic kidney disease (CKD) that increases in prevalence with the decline of glomerular fltration rate (GFR). Another risk of hyperkalemia is the use of renin-angiotensin-aldosterone sys
Externí odkaz:
https://doaj.org/article/754e3d1617bf480aa335ed61423da6a9
Autor:
Alejandro E. Cañas, Hayden R. Troutt, Luohua Jiang, Sam Tonthat, Omar Darwish, Antoney Ferrey, Shahram Lotfipour, Kamyar Kalantar-Zadeh, Ramy Hanna, Wei Ling Lau
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-11 (2023)
Abstract Background The KBindER (K+ Binders in Emergency Room and hospitalized patients) clinical trial is the first head-to-head evaluation of oral potassium binders (cation-exchange resins) for acute hyperkalemia therapy. Methods Emergency room and
Externí odkaz:
https://doaj.org/article/39eddc3039f04b63924a910384f854e8